Antibody Treatment Blocks Gut Toxin in Kidney Fibrosis
Here’s a summary of teh provided text, focusing on the key findings and the research process:
Key Findings:
Patients with diabetic kidney disease have significantly higher levels of a compound called corisin in their blood and urine compared to healthy individuals.
The concentration of corisin is directly linked to the severity of kidney damage.
Corisin accelerates aging in kidney cells, leading to inflammation, cell death, scar tissue buildup, and ultimately, loss of kidney function and worsening fibrosis.
Corisin travels from the gut to the kidneys by attaching to albumin, a common protein in the blood. It then detaches from albumin in the kidneys and attacks the structures responsible for filtering blood and urine.
Research Process:
- Analysis of patient Samples: Researchers analyzed blood and urine samples from patients with diabetic kidney disease and compared them to healthy individuals.
- Animal Studies: The same results were observed in mice with kidney fibrosis. Researchers then tracked the effects of corisin on the kidneys of these mice.
- Tracking Corisin’s Journey: Researchers used computer simulations and laboratory experiments to trace the path of corisin from the gut to the bloodstream and then to the kidneys.
- Collaboration: The research involved collaboration between multiple groups at the University of illinois and Mie University in Japan, including experts in microbiology, immunology, chemical engineering, and biomolecular engineering.